Those infected with the newly dominant subvariants may develop a cough, runny nose, sore throat, fatigue, headaches and muscle pains but are less likely to experience shortness of breath or lose their senses of taste and smell.
Joseph Khabbaza, MD, a pulmonary and critical care physician at Cleveland Clinic, told the Times patients tend to develop upper respiratory symptoms “from the vocal cords to the tip of the nose,” while adding he has seen more patients with painful sinus congestion and severe sore throats as the subvariants have gained traction across the nation.
